There are still lots of open positions. Let's find the one that's right for you.
The Vice President of Investor Relations and Corporate Communications will be responsible for engaging key stakeholders to build awareness and education on Zentalis’s strategy to advance its lead clinical asset azenosertib, a potentially first-in-class and best-in-class Wee1 inhibitor, for patients with Cyclin E1+ platinum-resistant ovarian cancer and other solid tumor indications. This functional leader will report directly to the Chief Business Officer and work closely with the executive team to establish and execute on a successful engagement strategy and plan that communicates the Company’s business objectives and major corporate activities to all key stakeholders, including the investment community, media, and employees. He/she will manage all external and internal communications, including investor relations, media and public relations, social media, and employee communications.